Related Experiment Video
Updated: May 25, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Acute coronary syndromes in patients with chronic kidney disease
Beata Franczyk-Skóra1, Anna Gluba, Maciej Banach
1Department of Hypertension, WAM University Hospital in Lodz, Medical University of Lodz, Zeromskiego 113, 90-549 Lodz, Poland. maciejbanach@aol.co.uk.
Insights
Chronic kidney disease (CKD) patients face high cardiovascular risks. Treatment should mirror that for normal kidney function, with careful dose adjustments, and revascularization may benefit acute coronary syndrome patients.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Chronic kidney disease (CKD) significantly increases cardiovascular morbidity and mortality.
- Accelerated atherosclerosis in CKD patients contributes to renal function decline.
- Limited randomized studies exist for heart failure treatment in CKD patients due to exclusions.
Purpose of the Study:
- To review current understanding of cardiovascular disease management in CKD patients.
- To highlight the need for evidence-based treatment strategies for heart failure and coronary artery disease in CKD.
- To assess the role of revascularization in acute coronary syndrome (ACS) within the CKD population.
Main Methods:
- Review of existing literature and clinical data on cardiovascular disease in CKD.
- Analysis of treatment approaches for heart failure and coronary artery disease in CKD.
- Evaluation of outcomes for revascularization procedures in CKD patients with ACS.
Main Results:
- CKD patients require cardiovascular treatment similar to non-CKD patients, with crucial dose titration to avoid adverse events.
- Revascularization procedures in CKD patients with ACS appear beneficial long-term despite high risk.
- Data gaps exist, necessitating further large-scale clinical trials.
Conclusions:
- Cardiovascular care for CKD patients should be individualized, focusing on optimal drug dosing and risk management.
- Revascularization is a potentially valuable intervention for ACS in CKD patients.
- Further research is essential to establish definitive treatment guidelines and confirm the safety and efficacy of various interventions.
Abstract:
Chronic kidney disease (CKD) is associated with high cardiovascular morbidity and mortality. The available data suggest that efforts to reduce mortality in the CKD population should be focused on treatment and prevention of, among others, coronary artery disease and congestive heart failure. Accelerated atherosclerosis present in CKD patients also leads to a decline in renal function. Definite data concerning the treatment of heart failure in CKD patients are lacking, because patients with significant renal impairment have mostly been excluded from randomized studies. Nevertheless, it seems that CKD patients should receive similar cardiovascular treatment to that used in patients with normal kidney function, but the doses of drugs ought to be titrated to achieve an optimal effect while avoiding adverse events. Several studies have also shown that despite the high risk, in patients with acute coronary syndrome (ACS), revascularization procedures in patients with CKD appear to be advantageous in the long run and are therefore justified. However, large clinical trials are needed to confirm the benefits and to identify possible disadvantages associated with various methods of treatment.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury II: Pathophysiology
